Diabetes Drug May Double the Risk of Diabetic Eye Disease in People Already at Risk

Tirzepatide use was associated with a little more than double the odds—115 percent—of developing PDR compared with those not on the medication, with most cases occurring in patients who already had mild retinal damage from diabetes.

The post Diabetes Drug May Double the Risk of Diabetic Eye Disease in People Already at Risk appeared first on Healthcare Communications Network.